Is magnesium supplementation nephrotoxic, particularly in patients with impaired renal function (eGFR <30 mL/min/1.73 m²) or acute kidney injury?

Is Magnesium Supplementation Nephrotoxic?

Magnesium supplementation is not inherently nephrotoxic but becomes extremely dangerous and potentially fatal in patients with severe renal impairment (creatinine clearance <20 mL/min) due to inability to excrete excess magnesium, leading to life-threatening hypermagnesemia. 1

Renal Safety Profile by Kidney Function

Normal to Moderate Renal Impairment (eGFR ≥30 mL/min)

• Magnesium supplementation is safe in patients with normal kidney function or mild-to-moderate CKD, as the kidney compensates through decreased tubular reabsorption to maintain adequate urinary magnesium excretion even when glomerular filtration rates are reduced. 2

• The kidney's compensatory mechanisms allow magnesium balance to remain normal despite declining renal function, preventing toxic accumulation in most CKD patients. 2

• Recent evidence demonstrates that magnesium administration in CKD patients is safe without concerns for severe hypermagnesemia or negative interference with bone metabolism, based on multiple clinical intervention studies. 3

• Higher dietary magnesium intake is actually associated with lower risk of kidney function decline (30% eGFR decline) and incident CKD in older adults, suggesting a protective rather than harmful effect. 4

Severe Renal Impairment (eGFR <30 mL/min)

• Absolute contraindication: creatinine clearance <20 mL/min. The kidney cannot excrete excess magnesium at this level of function, creating risk of potentially fatal hypermagnesemia. 1

• Use extreme caution between eGFR 20-30 mL/min, avoiding supplementation unless in life-threatening emergencies (e.g., torsades de pointes), and only with close monitoring. 1

• In end-stage renal disease, the limited ability to excrete magnesium loads may result in toxic serum concentrations, particularly when magnesium-containing drugs or antacids are administered. 2, 5

Mechanism of Toxicity Risk (Not Nephrotoxicity)

• The concern is hypermagnesemia, not kidney damage. Magnesium does not injure the kidneys; rather, failing kidneys cannot eliminate magnesium, allowing dangerous accumulation. 2

• Renal excretion is the major route of magnesium elimination, and when this pathway fails in advanced CKD, magnesium accumulates in serum, red cells, bone, and total body stores. 5

• Hypermagnesemia predicts cardiovascular events and all-cause mortality in CKD populations, with patients showing higher risk in both crude and adjusted analyses. 6

Clinical Algorithm for Safe Magnesium Use

Step 1: Assess Renal Function

• Check creatinine clearance or eGFR before any magnesium supplementation. 1
• If CrCl <20 mL/min → absolute contraindication (except life-threatening arrhythmias with intensive monitoring). 1
• If CrCl 20-30 mL/min → avoid unless emergency; use reduced doses with close monitoring if essential. 1
• If CrCl 30-60 mL/min → use reduced doses with close monitoring. 1
• If CrCl >60 mL/min → standard dosing appropriate. 1

Step 2: Monitor Magnesium Levels

• Check serum magnesium at baseline, 2-3 weeks after starting supplementation, after any dose adjustment, and every 3 months once stable. 1
• In patients with CKD stage 3-4, monitor more frequently (every 2-4 weeks initially) due to accumulation risk. 1

Step 3: Adjust Dialysate Magnesium in Dialysis Patients

• For patients on hemodialysis or continuous renal replacement therapy (CRRT), use dialysis solutions containing magnesium to prevent hypomagnesemia rather than oral supplementation. 7
• Hypomagnesemia occurs in 60-65% of critically ill patients on CRRT, particularly with regional citrate anticoagulation. 7
• Commercial KRT solutions enriched with magnesium can be safely used as dialysis and replacement fluids to prevent KRT-related hypomagnesemia. 7

Critical Pitfalls to Avoid

• Never assume "a little magnesium won't hurt" in advanced CKD. Even modest supplementation can cause life-threatening hypermagnesemia when CrCl <20 mL/min. 1

• Avoid magnesium-containing antacids (e.g., magnesium hydroxide, Maalox, Mylanta) in patients with CKD, as these were largely discontinued decades ago after reports of toxic magnesium levels. 5

• Do not overlook acute kidney injury superimposed on CKD, as these patients have even less capacity to excrete magnesium than their baseline eGFR suggests. 1

• Magnesium supplementation should be used with caution in CKD populations given the association between hypermagnesemia and adverse cardiovascular outcomes and mortality. 6

Special Considerations in CKD-Mineral Bone Disorder

• Despite safety concerns, magnesium may have beneficial effects on vascular calcification and mineral metabolism in CKD patients when used appropriately. 8, 3

• Clinical trials have shown that magnesium-based interventions can improve parameters of vascular function and calcification in CKD, though results have been contradictory across studies. 8

• The ongoing Dial-Mag Canada trial (NCT04079582) will evaluate effects of different dialysate magnesium concentrations in >25,000 hemodialysis patients, with completion expected in 2028. 8